Serum tetranectin in patients with acute pelvic inflammatory disease (PID): Correlation to clinical and laboratory findings

References

• Clemmensen I, Petersen L C, Kluft C. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem 1986; 156: 327–33
   PubMedGoogle Scholar
• Fuhlendorff J, Clemmensen I, Magnusson S. Primary structure of tetranectin a plasminogen kringle 4 binding plasma protein: homology with asialoglycoprotein receptors and cartilage proteoglycan core protein. Biochemistry 1987; 26: 6757–64
   PubMed Web of Science ®Google Scholar
• Kluft C, Los P, Clemmensen I. Immunological studies on a plasminogen kringle 4 binding protein in plasma. Thromb Haemost 1985; 54: 277
   Google Scholar
• Hagdall C K, Høgdall E V, Jsrgensen L N, Clemmensen I. Changes in plasma tetranectin following hip surgery with or without thrombotic complications. Thromb Res 1992; 67: 399–405
   Google Scholar
• Jensen B A, Clemmensen I. Plasma tetranectin is reduced in cancer and related to metastasia. Cancer 1988; 62: 869–72
   PubMedGoogle Scholar
• Høgdall C K, Høgdall E VS, Hørding U. Plasma tetranectin and ovarian neoplasms. Gynecol Oncol 1991; 43: 103–7
   PubMed Web of Science ®Google Scholar
• Høgdall E V, Høgdall C K, Clemmensen I, Nargaard-Pedersen B, Loft AG. Tetranectin in amniotic fluid maternal serum and fetal fluids. Scand J Clin Lab Invest 1991; 51: 411–5
   PubMed Web of Science ®Google Scholar
• Høgdall C K, Sölétormos G, Nielsen D, Nørgaard-Pedersen B, Dombernowsky P, Clemmensen I. Prognostic value of serum tetranectin in patients with metastatic breast cancer. Acta Oncol 1993; 32: 631–6
   PubMed Web of Science ®Google Scholar
• Borregaard N, Christensen L, Bjerrum O W, Birgens H S, Clemmensen I. Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase. J Clin Invest 1990; 85: 408–16
   PubMed Web of Science ®Google Scholar
• Dörr PJ, Brommer E J, Dooijewaard G, Vemer HM. Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory disease. Thromb Haemost 1992; 68: 102–5
   PubMed Web of Science ®Google Scholar
• Weström L. Diagnostic, aetiology and prognosis of acute salpingitis (thesis). Sweden Student-litteratur, Lund 1976
   Google Scholar
• Brihmer C, Kallings I, Nord C E, Brundin J. Salpingitis: aspects of diagnosis and etiology: a 4-year study from a Swedish capital hospital. Eur J Obstet Gynecol Reprod Biol 1987; 24: 211–20
   PubMedGoogle Scholar
• Høgdall CK. Stability of tetranectin concentration in blood samples. Fibrinolysis 1994; 8: 101–3
   Google Scholar
• Anonymous. Manual of Clinical Microbiology: 4th eds, E D Lemotte. American Society for Microbiology, Washington, DC 1985
   Google Scholar
• Jensen B A, McNair P, Hyldstrup L, Clemmensen I. Plasma tetranectin in healthy male and female individuals measured by enzyme-linked immunosorbent assay. J Lab Clin Med 1987; 110: 612–7
   PubMed Web of Science ®Google Scholar
• Pocock S J, Geller N L, Tsiatis AA. The analysis of multiple endpoints in clinical trials. Biometrics 1987; 43: 487–98
   PubMed Web of Science ®Google Scholar
• Bast R C, Feeney M, Lazarus H, Nadler LM. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981; 68: 1331–7
   PubMed Web of Science ®Google Scholar
• Halila H, Lehtovirta P, Stenman UH. Tumour-associated trypsin inhibitor (TATI) in ovarian cancer. Br J Cancer 1988; 57: 304–7
   PubMed Web of Science ®Google Scholar
• Daoud E, Bodor G. CA-125 concentrations in malignant and nonmalignant disease [clinical conference]. Clin Chem 1991; 37: 1968–74
   Google Scholar
• Paavonen J, Lehtinen M, Lehto M. Concentrations of tumor-associated trypsin inhibitor and C-reactive protein in serum in acute pelvic inflammatory disease. Clin Chem 1989; 35: 869–71
   PubMed Web of Science ®Google Scholar
• Morrow J F, Stearman R S, Peltzman C G, Potter DA. Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci USA 1981; 78: 4718
   PubMed Web of Science ®Google Scholar
• Ricca G A, McLean J W, Taylor JM. Kinetics of induction of alpha I-acid glycoprotein. Ann N Y Acad Sci 1982; 389: 88–105
   PubMedGoogle Scholar
• Castell J V, Gomez Lechon M J, David M, Hirano T, Kishimoto T, Heinrich PC. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988; 232: 347–50
   PubMed Web of Science ®Google Scholar
• Wewer U M, Albrechtsen R. Tetranectin a plasminogen kringle 4-binding protein. Cloning and gene expression pattern in human colon cancer. Lab Invest 1992; 67: 253–62
   PubMedGoogle Scholar
• Berglund L, Petersen TE. The gene structure of tetranectin a plasminogen binding protein. FEBS Lett 1992; 309: 15–9
   PubMedGoogle Scholar
• Christensen L, Johansen N, Jensen B A, Clemmensen I. Immunohistochemical localization of a novel, human plasma protein, tetranectin, in human endocrine tissues. Histochemistry 1987; 87: 195–9
   PubMedGoogle Scholar